Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.

about

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease

P2860

Q57093464-5236631F-E590-43E6-B506-8FEC28F06322 Q58740258-BBABBC73-B561-4628-BBD1-13B2021326A9

P2860

Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.

Item

http://www.wikidata.org/entity/Q41623607

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Effects of Dapagliflozin on Bo ...... pen-label, Uncontrolled Study.

@en

type

Item

label

Effects of Dapagliflozin on Bo ...... pen-label, Uncontrolled Study.

@en

prefLabel

Effects of Dapagliflozin on Bo ...... pen-label, Uncontrolled Study.

@en

P1476

Effects of Dapagliflozin on Bo ...... pen-label, Uncontrolled Study.

@en

P2093

Hiroshi Tobita

http://www.w3.org/2001/XMLSchema#string

Shuichi Sato

http://www.w3.org/2001/XMLSchema#string

Shunji Ishihara

http://www.w3.org/2001/XMLSchema#string

Tatsuya Miyake

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Kinoshita

http://www.w3.org/2001/XMLSchema#string

P2860

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight

Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women.

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

P304

13-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CURTHERES.2017.07.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28912902

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5587885

http://www.w3.org/2001/XMLSchema#string

Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.

about

P2860

P2860

Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932